October 28, 2019
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development
FOSTER CITY, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gilead Sciences Inc. (Nasdaq: GILD) and Glympse Bio, Inc., today announced that the companies…